Oclacitinib maleate is a synthetic janus kinase inhibitor used as a veterinary active pharmaceutical ingredient. It is primarily employed in the control of atopic dermatitis and pruritus from allergic dermatitis in dogs aged at least 12 months.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1640292-55-2
JAKI
active pharmaceutical ingredient for veterinary use
OCLACITINIB MALEATE
active pharmaceutical ingredient
Quinapyramine dichloride
veterinary active pharmaceutical ingredient
P-(1-(Butylamino)-1-methylethyl)phosphinic acid
veterinary active pharmaceutical ingredient
Nitroscanate
veterinary active pharmaceutical ingredient
MELENGESTROL ACETATE
veterinary active pharmaceutical ingredient
Sodium glycodeoxycholate
Bile acid salt human metabolite
DIETHYLCARBAMAZINE CITRATE
active pharmaceutical ingredient
(Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide
VQIGDTLRBSNOBV-BTJKTKAUSA-N
CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3.C(=C\C(=O)O)\C(=O)O